Generate Biomedicines
Generate Biomedicines Raises $370M in Series C
Generate Biomedicines Raises $370M in Series C
Generate Biomedicines has successfully raised $370M in a Series C at a $2B valuation led by Flagship Pioneering, T. Rowe Price, Fidelity, NVIDIA, Alaska Permanent Fund.
Company Overview
Generate Biomedicines is a Biotech company headquartered in 1 Main Street, Cambridge, MA 02142, founded in 2018 with 200+ employees.
Generative biology AI drug discovery
Fundraising Details
- Amount Raised: $370M
- Round Type: Series C
- Valuation: $2B
- Date: 2024-11-19
- Investors: Flagship Pioneering, T. Rowe Price, Fidelity, NVIDIA, Alaska Permanent Fund
About Generate Biomedicines
Generative biology AI drug discovery The company is positioned in the Biotech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: 1 Main Street, Cambridge, MA 02142
- Founded: 2018
- Team Size: 200+
- Industry: Biotech
What This Means
This funding round demonstrates strong investor confidence in Generate Biomedicines's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Generate Biomedicines's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $2B valuation marks an important milestone for Generate Biomedicines, positioning the company among notable players in the Biotech industry.
Looking Ahead
With this new capital, Generate Biomedicines is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2024-11-19. For more information about Generate Biomedicines, visit their headquarters at 1 Main Street, Cambridge, MA 02142.
Company Info
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started